Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.

NCT03078907 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Selexipag
DRUG: Placebo

Sponsor

Actelion